Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring W, Robison LL. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol. 2009 May 10. 27(14):2328-38. [Medline]. [Full Text].
Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006 Oct 12. 355(15):1572-82. [Medline].
Hudson MM, Ness KK, Gurney JG, Mulrooney DA, Chemaitilly W, Krull KR. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013 Jun 12. 309(22):2371-81. [Medline].
Park ER, Li FP, Liu Y, Emmons KM, Ablin A, Robison LL. Health insurance coverage in survivors of childhood cancer: the Childhood Cancer Survivor Study. J Clin Oncol. 2005 Dec 20. 23(36):9187-97. [Medline].
Schrag NM, McKeown RE, Jackson KL, Cuffe SP, Neuberg RW. Stress-related mental disorders in childhood cancer survivors. Pediatr Blood Cancer. 2008 Jan. 50(1):98-103. [Medline].
Nishino T, Osawa M, Iwama A. New approaches to expand hematopoietic stem and progenitor cells. Expert Opin Biol Ther. 2012 Jun. 12(6):743-56. [Medline].
Duell T, van Lint MT, Ljungman P, et al. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med. 1997. 126:184-192.
Armenian SH, Sun CL, Kawashima T, Arora M, Leisenring W, Sklar CA. Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood. 2011 Aug 4. 118(5):1413-20. [Medline].
[Guideline] Rizzo JD, Wingard JR, Tichelli A, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT). Bone Marrow Transplant. 2006. 37:249-261.
[Guideline] Schmitz N, Eapen M, Horowitz MM, Zhang MJ, Klein JP, Rizzo JD. Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood. 2006 Dec 15. 108(13):4288-90. [Medline].
Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012 Mar. 18(3):348-71. [Medline].
Bhatia S, Davies SM, Scott Baker K, Pulsipher MA, Hansen JA. NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: etiology and pathogenesis of late effects after HCT performed in childhood--methodologic challenges. Biol Blood Marrow Transplant. 2011 Oct. 17(10):1428-35. [Medline].
Bunin N, Small T, Szabolcs P, Baker KS, Pulsipher MA, Torgerson T. NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: persistent immune deficiency in pediatric transplant survivors. Biol Blood Marrow Transplant. 2012 Jan. 18(1):6-15. [Medline].
Nieder ML, McDonald GB, Kida A, Hingorani S, Armenian SH, Cooke KR. National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage and dysfunction. Biol Blood Marrow Transplant. 2011 Nov. 17(11):1573-84. [Medline].
Parsons SK, Phipps S, Sung L, Baker KS, Pulsipher MA, Ness KK. NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: health-related quality of life, functional, and neurocognitive outcomes. Biol Blood Marrow Transplant. 2012 Feb. 18(2):162-71. [Medline]. [Full Text].
Dvorak CC, Gracia CR, Sanders JE, et al. NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks. Biol Blood Marrow Transplant. 2011. 17:1725-38.
Pulsipher MA, Skinner R, McDonald GB, Hingorani S, Armenian SH, Cooke KR. National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-specific long-term follow-up guidelines. Biol Blood Marrow Transplant. 2012 Mar. 18(3):334-47. [Medline].
Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol. 2011 Jun 1. 29(16):2230-9. [Medline].
Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood. 1987 Feb. 69(2):369-80. [Medline].
Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006 Apr 27. 354(17):1813-26. [Medline].
Rnard C, Barlogis V, Mialou V, Galambrun C, Bernoux D, Goutagny MP. Lymphocyte subset reconstitution after unrelated cord blood or bone marrow transplantation in children. Br J Haematol. 2011 Feb. 152(3):322-30. [Medline].
Kook H, Goldman F, Giller R, et al. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: functional analyses of lymphocytes and correlation with immunophenotypic recovery following transplantation. Clin Diagn Lab Immunol. 1997 Jan. 4(1):96-103. [Medline].
Ljungman P, Cordonnier C, Einsele H, Englund J, Machado CM, Storek J. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant. 2009 Oct. 44(8):521-6. [Medline].
Atsuta Y, Suzuki R, Yamamoto K, Terakura S, Iida H, Kohno A. Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation. Bone Marrow Transplant. 2006 Feb. 37(3):289-96. [Medline].
Sohn SK, Kim DH, Baek JH, Kim JG, Lee KB, Lee KH. Risk-factor analysis for predicting progressive- or quiescent-type chronic graft-versus-host disease in a patient cohort with a history of acute graft-versus-host disease after allogeneic stem cell transplantation. Bone Marrow Transplant. 2006 Apr. 37(7):699-708. [Medline].
Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol. 2005 Aug 1. 23(22):5074-87. [Medline].
Pavletic SZ, Smith LM, Bishop MR, Lynch JC, Tarantolo SR, Vose JM. Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation. Am J Hematol. 2005 Apr. 78(4):265-74. [Medline].
Nishio N, Yagasaki H, Takahashi Y, Muramatsu H, Hama A, Tanaka M. Late-onset non-infectious pulmonary complications following allogeneic hematopoietic stem cell transplantation in children. Bone Marrow Transplant. 2009 Sep. 44(5):303-8. [Medline].
Patey-Mariaud de Serre N, Reijasse D, Verkarre V, Canioni D, Colomb V, Haddad E. Chronic intestinal graft-versus-host disease: clinical, histological and immunohistochemical analysis of 17 children. Bone Marrow Transplant. 2002 Feb. 29(3):223-30. [Medline].
Browning B, Thormann K, Seshadri R, Duerst R, Kletzel M, Jacobsohn DA. Weight loss and reduced body mass index: a critical issue in children with multiorgan chronic graft-versus-host disease. Bone Marrow Transplant. 2006 Mar. 37(5):527-33. [Medline].
Gilman AL, Kooy NW, Atkins DL, Ballas Z, Rumelhart S, Holida M. Complete heart block in association with graft-versus-host disease. Bone Marrow Transplant. 1998 Jan. 21(1):85-8. [Medline].
Boyer MW, Gross TG, Loechelt B, Leemhuis T, Filipovich A, Harris RE. Low risk of graft-versus-host disease with transplantation of CD34 selected peripheral blood progenitor cells from alternative donors for Fanconi anemia. J Pediatr Hematol Oncol. 2003 Nov. 25(11):890-5. [Medline].
Guthery SL, Heubi JE, Filipovich A. Enteral metronidazole for the prevention of graft versus host disease in pediatric marrow transplant recipients: results of a pilot study. Bone Marrow Transplant. 2004 Jun. 33(12):1235-9. [Medline].
Koc S, Leisenring W, Flowers ME, Anasetti C, Deeg HJ, Nash RA. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood. 2002 Jul 1. 100(1):48-51. [Medline].
Martin PJ, Storer BE, Rowley SD, Flowers ME, Lee SJ, Carpenter PA. Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease. Blood. 2009 May 21. 113(21):5074-82. [Medline].
Lee SJ, Vogelsang G, Gilman A, Weisdorf DJ, Pavletic S, Antin JH. A survey of diagnosis, management, and grading of chronic GVHD. Biol Blood Marrow Transplant. 2002. 8(1):32-9. [Medline].
Jacobsohn DA, Chen AR, Zahurak M, Piantadosi S, Anders V, Bolanos-Meade J. Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease. J Clin Oncol. 2007 Sep 20. 25(27):4255-61. [Medline].
Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation. 2006 May 27. 81(10):1390-7. [Medline].
Gao L, Zhang Y, Hu B, Liu J, Kong P, Lou S, et al. Phase II Multicenter, Randomized, Double-Blind Controlled Study of Efficacy and Safety of Umbilical Cord-Derived Mesenchymal Stromal Cells in the Prophylaxis of Chronic Graft-Versus-Host Disease After HLA-Haploidentical Stem-Cell Transplantation. J Clin Oncol. 2016 Aug 20. 34 (24):2843-50. [Medline].
Kanold J, Paillard C, Halle P, D'Incan M, Bordigoni P, Demeocq F. Extracorporeal photochemotherapy for graft versus host disease in pediatric patients. Transfus Apher Sci. 2003 Feb. 28(1):71-80. [Medline].
Calzavara Pinton P, Porta F, Izzi T, et al. Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease. Haematologica. 2003. 88:1169-1175.
Elad S, Or R, Resnick I, Shapira MY. Topical tacrolimus--a novel treatment alternative for cutaneous chronic graft-versus-host disease. Transpl Int. 2003. 16:665-670.
Socie G, Curtis RE, Deeg HJ, Sobocinski KA, Filipovich AH, Travis LB. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol. 2000 Jan. 18(2):348-57. [Medline].
Leisenring W, Friedman DL, Flowers ME, Schwartz JL, Deeg HJ. Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation. J Clin Oncol. 2006 Mar 1. 24(7):1119-26. [Medline].
Danner-Koptik KE, Majhail NS, Brazauskas R, Wang Z, Buchbinder D, Cahn JY. Second malignancies after autologous hematopoietic cell transplantation in children. Bone Marrow Transplant. 2013 Mar. 48(3):363-8. [Medline].
Kolb HJ, Guenther W, Duell T, et al. Cancer after bone marrow transplantation. IBMTR and EBMT/EULEP Study Group on Late Effects. Bone Marrow Transplant. 1992. 10 Suppl 1:135-138.
Deeg HJ, Socie G. Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood. 1998 Mar 15. 91(6):1833-44. [Medline].
aya CV, Fung JJ, Nalesnik MA, et al. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation. 1999. 68:1517-1525.
Penn I, Hammond W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patients. Transplant Proc. 1969. 1:106-112.
Yufu Y, Kimura M, Kawano R, Noguchi Y, Takatsuki H, Uike N. Epstein-Barr virus-associated T cell lymphoproliferative disorder following autologous blood stem cell transplantation for relapsed Hodgkin's disease. Bone Marrow Transplant. 2000 Dec. 26(12):1339-41. [Medline].
Cohen JI. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine (Baltimore). 1991. 70:137-160.
Sklar CA. Growth and neuroendocrine dysfunction following therapy for childhood cancer. Pediatr Clin North Am. 1997 Apr. 44(2):489-503. [Medline].
Bakker B, Oostdijk W, Geskus RB, Stokvis-Brantsma WH, Vossen JM, Wit JM. Patterns of growth and body proportions after total-body irradiation and hematopoietic stem cell transplantation during childhood. Pediatr Res. 2006 Feb. 59(2):259-64. [Medline].
Cohen A, Rovelli A, Bakker B, Uderzo C, van Lint MT, Esperou H. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT. Blood. 1999 Jun 15. 93(12):4109-15. [Medline].
Afify Z, Shaw PJ, Clavano-Harding A, Cowell CT. Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide. Bone Marrow Transplant. 2000. 25:1087-1092.
Chemaitilly W, Boulad F, Heller G, Kernan NA, Small TN, O'Reilly RJ. Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation. Bone Marrow Transplant. 2007 Jul. 40(1):29-35. [Medline].
Shalet SM. Irradiation-induced growth failure. Clin Endocrinol Metab. 1986 Aug. 15(3):591-606. [Medline].
Shalet SM, Clayton PE, Price DA. Growth and pituitary function in children treated for brain tumours or acute lymphoblastic leukaemia. Horm Res. 1988. 30(2-3):53-61. [Medline].
Sanders JE, Guthrie KA, Hoffmeister PA, Woolfrey AE, Carpenter PA, Appelbaum FR. Final adult height of patients who received hematopoietic cell transplantation in childhood. Blood. 2005 Feb 1. 105(3):1348-54. [Medline].
Sklar CA, Mertens AC, Mitby P, Occhiogrosso G, Qin J, Heller G. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab. 2002 Jul. 87(7):3136-41. [Medline].
Ergun-Longmire B, Mertens AC, Mitby P, Qin J, Heller G, Shi W. Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab. 2006 Sep. 91(9):3494-8. [Medline].
Woodmansee WW, Zimmermann AG, Child CJ, Rong Q, Erfurth EM, Beck-Peccoz P. Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS. Eur J Endocrinol. 2013 Apr. 168(4):565-73. [Medline].
Mackenzie S, Craven T, Gattamaneni HR, Swindell R, Shalet SM, Brabant G. Long-term safety of growth hormone replacement after CNS irradiation. J Clin Endocrinol Metab. 2011 Sep. 96(9):2756-61. [Medline].
Johnston RJ, Wallace WH. Normal ovarian function and assessment of ovarian reserve in the survivor of childhood cancer. Pediatr Blood Cancer. 2009 Aug. 53(2):296-302. [Medline].
Richardson SJ, Senikas V, Nelson JF. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab. 1987 Dec. 65(6):1231-7. [Medline].
Treloar AE. Menstrual cyclicity and the pre-menopause. Maturitas. 1981 Dec. 3(3-4):249-64. [Medline].
Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005 Jul 1. 62(3):738-44. [Medline].
Sarafoglou K, Boulad F, Gillio A, Sklar C. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr. 1997 Feb. 130(2):210-6. [Medline].
Liu J, Malhotra R, Voltarelli J, Stracieri AB, Oliveira L, Simoes BP. Ovarian recovery after stem cell transplantation. Bone Marrow Transplant. 2008 Feb. 41(3):275-8. [Medline].
Brachet C, Heinrichs C, Tenoutasse S, Devalck C, Azzi N, Ferster A. Children with sickle cell disease: growth and gonadal function after hematopoietic stem cell transplantation. J Pediatr Hematol Oncol. 2007 Jul. 29(7):445-50. [Medline].
Lie Fong S, Laven JS, Hakvoort-Cammel FG, Schipper I, Visser JA, Themmen AP. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mllerian hormone. Hum Reprod. 2009 Apr. 24(4):982-90. [Medline].
Petryk A, Bergemann TL, Polga KM, Ulrich KJ, Raatz SK, Brown DM. Prospective study of changes in bone mineral density and turnover in children after hematopoietic cell transplantation. J Clin Endocrinol Metab. 2006 Mar. 91(3):899-905. [Medline].
Gallagher JC. Effect of early menopause on bone mineral density and fractures. Menopause. 2007 May-Jun. 14(3 Pt 2):567-71. [Medline].
Jacobsen BK, Knutsen SF, Fraser GE. Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study. J Clin Epidemiol. 1999 Apr. 52(4):303-7. [Medline].
de Kleijn MJ, van der Schouw YT, Verbeek AL, Peeters PH, Banga JD, van der Graaf Y. Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol. 2002 Feb 15. 155(4):339-45. [Medline].
Mondul AM, Rodriguez C, Jacobs EJ, Calle EE. Age at natural menopause and cause-specific mortality. Am J Epidemiol. 2005 Dec 1. 162(11):1089-97. [Medline].
Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M. Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med. 2009 Feb 5. 360(6):573-87. [Medline].
Yao S, McCarthy PL, Dunford LM, Roy DM, Brown K, Paplham P. High prevalence of early-onset osteopenia/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy. Bone Marrow Transplant. 2008 Feb. 41(4):393-8. [Medline].
Salooja N, Szydlo RM, Socie G, Rio B, Chatterjee R, Ljungman P. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet. 2001 Jul 28. 358(9278):271-6. [Medline].
Winther JF, Boice JD Jr, Frederiksen K, Bautz A, Mulvihill JJ, Stovall M. Radiotherapy for childhood cancer and risk for congenital malformations in offspring: a population-based cohort study. Clin Genet. 2009 Jan. 75(1):50-6. [Medline]. [Full Text].
Nagarajan R, Robison LL. Pregnancy outcomes in survivors of childhood cancer. J Natl Cancer Inst Monogr. 2005. (34):72-6. [Medline].
Bakker B, Massa GG, Oostdijk W, Van Weel-Sipman MH, Vossen JM, Wit JM. Pubertal development and growth after total-body irradiation and bone marrow transplantation for haematological malignancies. Eur J Pediatr. 2000 Jan-Feb. 159(1-2):31-7. [Medline].
Somali M, Mpatakoias V, Avramides A, Sakellari I, Kaloyannidis P, Smias C. Function of the hypothalamic-pituitary-gonadal axis in long-term survivors of hematopoietic stem cell transplantation for hematological diseases. Gynecol Endocrinol. 2005 Jul. 21(1):18-26. [Medline].
Anserini P, Chiodi S, Spinelli S, Costa M, Conte N, Copello F. Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counselling. Bone Marrow Transplant. 2002 Oct. 30(7):447-51. [Medline].
Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood. 1996 Apr 1. 87(7):3045-52. [Medline].
Sanders JE, Hoffmeister PA, Woolfrey AE, Carpenter PA, Storer BE, Storb RF. Thyroid function following hematopoietic cell transplantation in children: 30 years'' experience. Blood. 2009 Jan 8. 113(2):306-8. [Medline]. [Full Text].
Cohen A, Rovelli A, Merlo DF, van Lint MT, Lanino E, Bresters D. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study. J Clin Oncol. 2007 Jun 10. 25(17):2449-54. [Medline].
Hoffmeister PA, Madtes DK, Storer BE, Sanders JE. Pulmonary function in long-term survivors of pediatric hematopoietic cell transplantation. Pediatr Blood Cancer. 2006 Oct 15. 47(5):594-606. [Medline].
Cerveri I, Zoia MC, Fulgoni P, Corsico A, Casali L, Tinelli C. Late pulmonary sequelae after childhood bone marrow transplantation. Thorax. 1999 Feb. 54(2):131-5. [Medline].
Uderzo C, Pillon M, Corti P, Tridello G, Tana F, Zintl F. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties. Bone Marrow Transplant. 2007 Jun. 39(11):667-75. [Medline].
Faraci M, Barra S, Cohen A, Lanino E, Grisolia F, Miano M. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant. Int J Radiat Oncol Biol Phys. 2005 Dec 1. 63(5):1568-75. [Medline].
Rieger CT, Rieger H, Kolb HJ, Peterson L, Huppmann S, Fiegl M. Infectious complications after allogeneic stem cell transplantation: incidence in matched-related and matched-unrelated transplant settings. Transpl Infect Dis. 2009 Jun. 11(3):220-6. [Medline].
de Medeiros CR, Moreira VA, Pasquini R. Cytomegalovirus as a cause of very late interstitial pneumonia after bone marrow transplantation. Bone Marrow Transplant. 2000. 26:443-444.
Afessa B, Litzow MR, Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001 Sep. 28(5):425-34. [Medline].
Palmas A, Tefferi A, Myers JL, Scott JP, Swensen SJ, Chen MG. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol. 1998 Mar. 100(4):680-7. [Medline].
Patriarca F, Skert C, Bonifazi F, Sperotto A, Fili C, Stanzani M. Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation. Haematologica. 2006 Sep. 91(9):1268-72. [Medline].
Faraci M, Bekassy AN, De Fazio V, Tichelli A, Dini G. Non-endocrine late complications in children after allogeneic haematopoietic SCT. Bone Marrow Transplant. 2008. 41 Suppl 2:S49-57.
Cooke KR, Krenger W, Hill G, Martin TR, Kobzik L, Brewer J. Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation. Blood. 1998 Oct 1. 92(7):2571-80. [Medline].
Majeski EI, Paintlia MK, Lopez AD, Harley RA, London SD, London L. Respiratory reovirus 1/L induction of intraluminal fibrosis, a model of bronchiolitis obliterans organizing pneumonia, is dependent on T lymphocytes. Am J Pathol. 2003 Oct. 163(4):1467-79. [Medline]. [Full Text].
Soci G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A. Nonmalignant late effects after allogeneic stem cell transplantation. Blood. 2003 May 1. 101(9):3373-85. [Medline].
Original post:
Long-Term Effects of Bone Marrow Transplantation: Overview ...
- UC Irvine Study Reveals Risks Associated with Direct-to-Consumer Ads for Stem Cell and Exosome COVID-19 Therapies - India Education Diary - November 18th, 2023
- STEM | Description, Development, & Facts | Britannica - January 31st, 2023
- What is STEM Education? | Live Science - January 31st, 2023
- Science, Technology, Engineering, and Math, including Computer Science - ed - January 23rd, 2023
- What Does STEM Stand For? Definition, Degrees and More - January 23rd, 2023
- What Is STEM? - Definition & Resources for Teachers - January 23rd, 2023
- Science, technology, engineering, and mathematics - Wikipedia - January 23rd, 2023
- Stem Definition & Meaning - Merriam-Webster - January 23rd, 2023
- November: labblood-study | News and features - University of Bristol - November 7th, 2022
- Creative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStem, a Novel Cell Therapy for the... - November 7th, 2022
- Janssen to Highlight Latest Scientific Advances in Hematologic Diseases at ASH 2022 with Clinical and Real-World Data Across Innovative Pipeline and... - November 7th, 2022
- Type 2 Diabetes Stem Cell Therapy - Top U.S. Stem Cell ... - January 1st, 2022
- Cancer Drug Approvals from 2021 That Patients May Have Missed - Curetoday.com - January 1st, 2022
- Late effects in survivors of high-risk neuroblastoma following stem cell transplant with and without total body irradiation - DocWire News - January 1st, 2022
- The new life of a teenager with a strange tumor on his face after the operation - Market Research Telecast - January 1st, 2022
- Best of what was new in diabetes health for 2021 - Dickson Post - January 1st, 2022
- Hematopoietic Stem Cell Transplantation - StatPearls ... - December 22nd, 2021
- Autologous Stem Cell Transplant for Multiple Myeloma - December 22nd, 2021
- City of Hope presents leading-edge research on blood cancer therapies and its vaccine to reduce stem cell transplant complications at American Society... - December 22nd, 2021
- Adaptation Is Key to Advancing Care for Adult Patients With Leukemia - OncLive - December 22nd, 2021
- FDA Approves First Drug to Prevent Graft Versus Host Disease | FDA - FDA.gov - December 22nd, 2021
- Vera Therapeutics Announces Acquisition of Monoclonal Antibody From Pfizer to Treat BK Virus in Transplant Patients - Yahoo Finance - December 22nd, 2021
- After throwing goodbye party, woman with cancer finds hope close to home in Austin - Austin American-Statesman - December 22nd, 2021
- Dr. K.M. Cherian Heart Foundation & Educational Society Organized Cme Programme & Workshop On Cell Culture And Regenerative Medicine - APN... - December 22nd, 2021
- Namesake of new center a young man in love with the pursuit of knowledge - The Saint Anselm Crier - November 7th, 2021
- Red Cross blood drive focuses on sickle cell disease fight - Palladium-Item - November 7th, 2021
- Shockwave therapy brings new healing opportunities for heart attack patients and hope for people with spinal cord injuries - KULR-TV - November 7th, 2021
- 1st CRISPR Gene Editing Trial Slated to Open in Severe SCD Patients - Sickle Cell Anemia News - April 4th, 2021
- Transplant After CD19 CAR T-Cell Therapy Shows Durable Disease Control in Children, Young Adults With B-ALL - Cancer Network - April 4th, 2021
- Timely Bone Marrow Transplant by Fortis gives new lease of life to a patient with Multiple Myeloma - APN News - April 4th, 2021
- Kirron Kher is suffering with Multiple Myeloma: Know the causes, symptoms and more about this type of blood cancer - Jagran English - April 4th, 2021
- Decitabine Improved Outcomes for Patients With Refractory Prolonged Isolated Thrombocytopenia - Hematology Advisor - April 4th, 2021
- Lake in the Hills police officer and father of 4 kids battling rare cancer forced to retire - Lake and McHenry County Scanner - April 4th, 2021
- Insulin 100: How the road to a diabetes cure is yielding better treatments - News@UofT - April 4th, 2021
- Boxcar Scars Market |Exclusive Report on Latest Trends and Market Growth Opportunities - BioSpace - April 4th, 2021
- Merck Receives Positive EU CHMP Opinion for Updated Label of KEYTRUDA (pembrolizumab) To Include Results of Phase 3 KEYNOTE-361 Trial in Certain Adult... - April 4th, 2021
- BeyondSpring Announces Submission of New Drug Application to US FDA and China NMPA for Plinabulin and G-CSF Combination for the Prevention of... - April 4th, 2021
- Types of leukemia: Prevalence, treatment options, and prognosis - Medical News Today - February 14th, 2021
- Roche receives first FDA clearance for urine sample type for BK virus quantitative test to aid in the improvement of care for transplant patients -... - February 14th, 2021
- Energy drinks may damage the heart, researchers warnshould the FDA get involved? - Cardiovascular Business - February 14th, 2021
- FDA Approves G1 Therapeutics' COSELA (trilaciclib): The First and Only Myeloprotection Therapy to Decrease the Incidence of Chemotherapy-Induced... - February 14th, 2021
- Easter Ross mum of blood cancer tot urges would-be stem cell donors to show the love this Valentine's Day; Alness lass Adeline Davidson's plight... - February 14th, 2021
- Global Induced Pluripotent Market Positive Outlook, Revenue Generation & Leading Manufacturers, Forecast 2026||CELGENE CORPORATION; Astellas... - February 14th, 2021
- Leukemia in children: Symptoms, causes, treatment, outlook, and more - Medical News Today - February 7th, 2021
- After Bone Marrow Donation Saves 9-Year-Old Boy With Cancer, Boston Mom Fights To Raise Awareness - Here And Now - February 7th, 2021
- Understanding bone marrow transplant: The guidelines and the protocols - The New Indian Express - February 4th, 2021
- Why Cynata is hopeful its COVID treatment trial will succeed where others have failed - Business News Australia - February 4th, 2021
- Mobilize family caregivers to speed the rollout of Covid-19 vaccines - STAT - February 4th, 2021
- People With Cancer Should Receive COVID-19 Vaccine, Experts Say - Cancer Health Treatment News - February 4th, 2021
- Evotec and Medical Center Hamburg-Eppendorf Enter Partnership to Develop iPSC-Based Tissue Therapy f - PharmiWeb.com - February 4th, 2021
- APOE Tied to Increased Susceptibility to SARS-CoV-2 | ALZFORUM - Alzforum - February 4th, 2021
- Transforming Outcomes in Advanced CSCC with Immunotherapy - LWW Journals - February 4th, 2021
- Ashley Cain is living his worst nightmare as his baby daughter battles leukaemia in hospital - The Sun - February 4th, 2021
- Canada's blood supply has a diversity problem and people are dying because of it - CBC.ca - February 1st, 2021
- Autologous Stem Cell and Non Stem Based therapies Market Share, Size 2021 Global Industry Future Trends, Growth, Strategies,, Segmentation, In-depth... - February 1st, 2021
- Merck Receives Positive EU CHMP Opinion for Expanded Approval of KEYTRUDA (pembrolizumab) in Certain Patients With Relapsed or Refractory Classical... - February 1st, 2021
- Merck Presents Results From Head-to-Head Phase 3 KEYNOTE-598 Trial Evaluating KEYTRUDA (pembrolizumab) in Combination With Ipilimumab Versus KEYTRUDA... - February 1st, 2021
- Disabled People Are Waiting, Anxiously, For Lifesaving Covid-19 Vaccinations - Forbes - February 1st, 2021
- Family of Belfast woman Eimear Gooderham (25) share memories and dealing with grief in special UTV programme - Belfast Telegraph - February 1st, 2021
- Single-cell molecular profiling of all three components of the HPA axis reveals adrenal ABCB1 as a regulator of stress adaptation - Science Advances - February 1st, 2021
- The Need for New Biological Targets for Therapeutic Intervention in COPD - Pulmonology Advisor - February 1st, 2021
- What Patients With Cancer, Survivors Need to Know About the Emergency Use Authorization of COVID-19 Vaccine - Curetoday.com - December 19th, 2020
- Every Patient Treated With CRISPR Gene Therapy for Blood Diseases Continues to Thrive, More Than a Year On - Good News Network - December 19th, 2020
- Are Hiccups a Sign of the New Coronavirus? - Healthline - December 19th, 2020
- KEYTRUDA Plus LENVIMA Combination Demonstrated Statistically Significant Improvement in Overall Survival, Progression-Free Survival and Objective... - December 19th, 2020
- Covid-19 can have impact on heart too, say experts - Hindustan Times - December 19th, 2020
- Even if You've Had COVID-19 You Still Need the Vaccine - Healthline - December 19th, 2020
- The Link Between Cancer and Metabolic Dysfunction - Technology Networks - December 19th, 2020
- Diamyd Medical and Critical Path Institute announce data sharing collaboration to develop advanced drug development tools in type 1 diabetes -... - December 19th, 2020
- Gene therapy gives man with sickle cell disease the chance for a better future - Science Codex - December 3rd, 2020
- Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Safety and Therapeutic Efficacy of Angiogenesis Induced by Intraarterial Autologous... - December 3rd, 2020
- Coronavirus Updates: The Latest Treatments and Vaccines - GovTech - December 3rd, 2020
- Graft Versus Host Disease (GVHD) Patient Population, Treatment Algorithm, Medical Practices And Epidemiology Forecast To 2030 - The Market Feed - December 3rd, 2020
- Government of Canada and JDRF Canada announce new research funding to accelerate stem cell-based therapies for type 1 diabetes - India Education Diary - December 3rd, 2020
- Coinfection: more than the sum of its parts - Science Codex - November 19th, 2020
- Angiocrine Bioscience Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to AB-205 (Universal E-CEL Cell Therapy) to... - November 17th, 2020
- FDA Approves Merck's KEYTRUDA in Combination With Chemotherapy for Patients With Locally Recurrent Unresectable or Metastatic Triple?Negative Breast... - November 17th, 2020
- Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection - DocWire News - November 17th, 2020
- Cleveland Clinic team draws a link between COVID-19 protection and the sleep aid melatonin - FierceBiotech - November 17th, 2020
- UH announces participation in clinical trial testing antibodies to treat COVID-19 in adults - News 5 Cleveland - November 7th, 2020